Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes

被引:48
作者
Kienle, D
Benner, A
Kröber, A
Winkler, D
Mertens, D
Bühler, A
Seiler, T
Jäger, UJ
Lichter, P
Döhner, H
Stilgenbauer, S
机构
[1] Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany
[2] DKFZ, German Canc Res Ctr, Cent Unit Biostat, Heidelberg, Germany
[3] DKFZ, Div Mol Genet, Heidelberg, Germany
[4] Med Univ Vienna, Dept Internal Med 1, Vienna, Austria
关键词
D O I
10.1182/blood-2005-04-1483
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mutation status and usage of specific VH genes such as V3-21 and V1-69 are potentially independent pathogenic and prognostic factors in chronic lymphocytic leukemia (CLL). To investigate the role of antigenic stimulation, we analyzed the expression of genes involved in B-cell receptor (BCR) signaling/activation, cell cycle, and apoptosis control in CLL using these specific VH genes compared to VH mutated (VH-MUT) and VH unmutated (VH-UM) CLL not using these VH genes. V3-21 cases showed characteristic expression differences compared to VH-MUT (up: ZAP70 [or ZAP-70]; down: CCND2, P27) and VH-UM (down: PI3K, CCND2, P27, CDK4, BAX) involving several BCR-related genes. Similarly, there was a marked difference between VH unmutated cases using the V1-69 gene and VH-UM (up: FOS; down: BLNK, SYK, CDK4, TP53). Therefore, usage of specific VH genes appears to have a strong influence on the gene expression pattern pointing to antigen recognition and ongoing BCR stimulation as a pathogenic factor in these CLL subgroups.
引用
收藏
页码:2090 / 2093
页数:4
相关论文
共 26 条
[1]   Survival of leukemic B cells promoted by engagement of the antigen receptor [J].
Bernal, A ;
Pastore, RD ;
Asgary, Z ;
Keller, SA ;
Cesarman, E ;
Liou, HC ;
Schattner, EJ .
BLOOD, 2001, 98 (10) :3050-3057
[2]   Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia [J].
Chen, LG ;
Widhopf, G ;
Huynh, L ;
Rassenti, L ;
Rai, KR ;
Weiss, A ;
Kipps, TJ .
BLOOD, 2002, 100 (13) :4609-4614
[3]   Mechanisms of disease: Chronic lymphocytic leukemia [J].
Chiorazzi, N ;
Rai, KR ;
Ferrarini, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) :804-815
[4]   Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia [J].
Damle, RN ;
Wasil, T ;
Fais, F ;
Ghiotto, F ;
Valetto, A ;
Allen, SL ;
Buchbinder, A ;
Budman, D ;
Dittmar, K ;
Kolitz, J ;
Lichtman, SM ;
Schulman, P ;
Vinciguerra, VP ;
Rai, KR ;
Ferrarini, M ;
Chiorazzi, N .
BLOOD, 1999, 94 (06) :1840-1847
[5]   Genomic aberrations and survival in chronic lymphocytic leukemia. [J].
Döhner, H ;
Stilgenbauer, S ;
Benner, A ;
Leupolt, E ;
Kröber, A ;
Bullinger, L ;
Döhner, K ;
Bentz, M ;
Lichter, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916
[6]   Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia [J].
Fält, S ;
Merup, M ;
Tobin, G ;
Thunberg, U ;
Gahrton, G ;
Rosenquist, R ;
Wennborg, A .
BLOOD, 2005, 106 (02) :681-689
[7]   Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia [J].
Ghiotto, F ;
Fais, F ;
Valetto, A ;
Albesiano, E ;
Hashimoto, S ;
Dono, M ;
Ikematsu, H ;
Allen, SL ;
Kolitz, J ;
Rai, KR ;
Nardini, M ;
Tramontano, A ;
Ferrarini, M ;
Chiorazzi, N .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (07) :1008-1016
[8]   BCR targets cyclin D2 via Btk and the p85α subunit of PI3-K to induce cell cycle progression in primary mouse B cells [J].
Glassford, J ;
Soeiro, I ;
Skarell, SM ;
Banerji, L ;
Holman, M ;
Klaus, GGB ;
Kadowaki, T ;
Koyasu, S ;
Lam, EWF .
ONCOGENE, 2003, 22 (15) :2248-2259
[9]   Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia [J].
Hamblin, TJ ;
Davis, Z ;
Gardiner, A ;
Oscier, DG ;
Stevenson, FK .
BLOOD, 1999, 94 (06) :1848-1854
[10]   Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes [J].
Kienle, DL ;
Korz, C ;
Hosch, B ;
Benner, A ;
Mertens, D ;
Habermann, A ;
Kröber, A ;
Jädger, U ;
Lichter, P ;
Döhner, H ;
Stilgenbauer, S .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3780-3792